Non-Surgical Fat Reduction Market Will Show Exponential Growth US$ 220 Mn by 2022
The high cost involved in the research and development of obesity drugs as well as limited financial support are together a great challenge to the growth of the obesity management market. Additionally, longer duration of research and development activities and the inclusion of clinical trials to test the drugs increase the overall expenditure.
View full press release